Evaluating the cost-effectiveness of treatment with third-generation cephalosporins
- 1 January 1992
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (1) , 99-105
- https://doi.org/10.1016/0732-8893(92)90063-y
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infectionsDiagnostic Microbiology and Infectious Disease, 1992
- Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 1992
- Impact of Cefotaxime and Ceftriaxone on the Bowel and Vaginal Flora after Single-Dose Prophylaxis in Vaginal HysterectomyDrugs, 1988
- What is the Cost of Nephrotoxicity Associated with Aminoglycosides?Annals of Internal Medicine, 1987
- Randomised comparison of ceftriaxone and cefamandole therapy in lower respiratory tract infections in an elderly populationJournal of Antimicrobial Chemotherapy, 1986
- Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitisThe Pediatric Infectious Disease Journal, 1986
- Managing the use and cost of antimicrobial agentsAntimicrobic Newsletter, 1986
- Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settingsAntimicrobial Agents and Chemotherapy, 1983
- Antibiotic management of surgically treated gangrenous or perforated appendicitis: Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazoneThe American Journal of Surgery, 1982
- Common Adverse Effects of Antibacterial Agents on Major Organ SystemsSurgical Clinics of North America, 1980